With a second production site dedicated to pharmaceutical packaging, SOMATER is decisively strengthening its presence in the health market. Obtaining ISO 15378 certification for the Theix site is the culmination of an industrial strategy aimed at ensuring the security of supply to our customers.
The ISO 15378 standard sets out Good Manufacturing Practices (GMP) applicable to primary packaging for the pharmaceutical industry. Its attribution to the Theix site validates an efficient and effective quality management system.
With its Savigny plant, SOMATER now has a high-performance industrial tool that guarantees the continuity of operations for the pharmaceutical market, making it possible to face major crises like the one we have been experiencing for months.
The new certification reinforces the link between SOMATER and its pharmaceutical clients. By combining industrial performance, capacity for innovation and securing needs, we offer them new prospects for cooperation. Here’s the proof: a major strategic project that we will present soon.